Depolarizing shift in the GABA-induced current reversal potential by lidocaine hydrochloride

Depolarizing shift in the GABA-induced current reversal potential by lidocaine hydrochloride
复制标题

DOI:
10.1016/j.brainres.2010.05.052
复制
发表时间:
2010-07-23
期刊:
影响因子:
2.9
通讯作者:
Ishibashi, Hitoshi
Ishibashi, Hitoshi
中科院分区:
医学3区
文献类型:
--
作者:
Nakahata, Yoshihisa;Miyamoto, Akiko;Ishibashi, Hitoshi

文献摘要

被引文献

相似文献

盐酸利多卡因(LC-HCl)被广泛用作局部麻醉剂,同时也有各种不良反应的报道,如癫痫发作。据报道,利多卡因可抑制多种通道和受体,包括GABA(A)受体。虽然GABA(A)受体介导的反应依赖于Cl-平衡电位(E-Cl),但关于LC-HCl对E-Cl的影响知之甚少。在本研究中,我们研究了LC-HCl对GABA诱导的电流在培养的大鼠海马神经元短杆菌肽穿孔膜片钳记录,这是已知的保持细胞内的Cl-浓度完整的影响。LC-HCl抑制GABA诱导的外向电流,并使GABA逆转电位(E-GABA)去极化移位。用传统的全细胞膜片钳方法不能保持细胞内Cl-浓度的完整性,不能观察到LC-HCl诱导的E-GABA正向位移。LC-HCl对E-GABA的作用可被Na ~+-K ~+-Cl ~-协同转运体(NKCC)和K ~+-Cl ~-协同转运体(K-CC)的阻断剂呋塞米或细胞外K ~+浓度的增加所抑制。无论是布美他尼,NKCC的特异性抑制剂,也没有Na+的外部解决方案有任何LC-HCl诱导的E-GABA移位的影响。QX-314是一种不透膜的利多卡因衍生物,不能使E-GABA转变为正电位。此外,LC-HCl引起培养的表达KCC 2的GT 1 -7细胞中的E-GABA的去极化移位,但不能改变不表达KCC 2的GT 1 -7细胞中的E-GABA。这些结果表明,LC-HCl诱导的正E-GABA移位是由于KCC 2的阻断。与LC-HCl对GABA(A)受体的直接作用一起,LC-HCl诱导的正E-GABA移位减少了中枢神经系统中的GABA能抑制。(C)2010 Elsevier BV保留所有权利。
Lidocaine hydrochloride (LC-HCl) is widely used as a local anesthetic, while various adverse effects of LC-HCl, such as seizures have also been reported. Lidocaine is reported to inhibit various channels and receptors including GABA(A) receptors. Although the GABA(A) receptor-mediated response depends on Cl- equilibrium potential (E-Cl), little is known about the effect of LC-HCl on E-Cl. In the present study, we investigated the effect of LC-HCl on GABA-induced currents in cultured rat hippocampal neurons with gramicidin-perforated patch-clamp recording which is known to keep the intracellular Cl- concentration intact. LC-HCl inhibited outward GABA-induced currents with depolarizing shift of the GABA reversal potential (E-GABA). The LC-HCl-induced positive E-GABA shift was not observed with conventional whole-cell patch-clamp method which cannot retain intact intracellular Cl- concentration. The LC-HCl action on E-GABA was inhibited by either furosemide, a blocker of both Na+-K+Cl- cotransporter (NKCC) and K+-Cl- cotransporter (K-CC), or an increase in extracellular K+ concentrations. Neither bumetanide, a specific inhibitor of NKCC, nor Na+-free external solution had any effect on the LC-HCl-induced E-GABA shift. QX-314, a membrane impermeable lidocaine derivative, failed to shift E-GABA to positive potential. Furthermore, LC-HCl caused a depolarizing shift of E-GABA in cultured GT1-7 cells expressing KCC2 but failed to change E-GABA in GT1-7 cells without expression of KCC2. These results suggest that the LC-HCl-induced positive E-GABA shift is due to a blockade of KCC2. Together with the direct LC-HCl action to GABA(A) receptors, the positive E-GABA shift induced by LC-HCl reduces the GABAergic inhibition in the central nervous system. (C) 2010 Elsevier B.V. All rights reserved.